# Consequences of irradiation on blood-brain tumor barrier model of Diffuse Midline Glioma: characterization of physical and metabolic properties

**Authors:** Marine Carroué, Eloise Happernegg, Flavie Perrot, Marie-Christine Boucau, Lucie Dehouck, Emmanuel Sevin, Mélanie Arcicasa, Joanne Balsamelli, Fumitaka Shimizu, Takashi Kanda, Angel M. Carcaboso, Robert-Alain Toillon, Maxime Culot, Samuel Meignan, Fabien Gosselet, Caroline Mysiorek

PMC · DOI: 10.1186/s12987-026-00778-6 · 2026-02-24

## TL;DR

This study examines how radiation affects the blood-brain tumor barrier in a pediatric brain tumor model, revealing changes in physical and metabolic properties.

## Contribution

The study introduces a novel in vitro model to characterize the effects of radiation on the blood-brain tumor barrier in diffuse midline glioma.

## Key findings

- Irradiation preserved endothelial permeability but caused Claudin-5 heterogeneity and reduced expression.
- Radiation modulated metabolic properties differently in endothelial cells and pericytes, with pericytes showing compensatory effects.
- P-gp/BCRP efflux pump activity remained functional post-irradiation, though less efficient, in both endothelial cells and pericytes.

## Abstract

Diffuse midline glioma (DMG) is a rare and aggressive pediatric brain tumor, with a median survival of less than 12 months. Due to its location in the pons, surgical resection is impossible, leaving radiation therapy as the only palliative treatment option. Unfortunately, radiation therapy yields minimal improvement in survival. Thus, characterization of the vascular component of the DMG microenvironment at the cellular and molecular levels following radiotherapy to improve therapeutic strategies.

A human syngeneic blood-brain tumor barrier (BBTB) in vitro model, comprising endothelial cells, pericytes and DMG cells was submitted to a single dose of radiation (2 Gγ to 6 Gγ) and was characterized for its physical and metabolic properties over a period of 7 days post-exposure. The results were then compared to the effects of the same irradiation protocol on a physiologic blood-brain barrier (BBB) model.

Following irradiation, the endothelial permeability of the BBB ECs and the BBTB ECs was preserved for up to 7 days but associated with Claudin-5 heterogeneous distribution at the ECs borders and decrease of expression after irradiation. Nevertheless, irradiation was found to potentiate the effect of TNFα on the physical integrity of the BBB, which was less important for the BBTB. The metabolic properties of the BBB and BBTB were modulated by radiation at the transcriptional level. Interestingly, different regulations were observed in endothelial cells and pericytes. Notably, pericytes have demonstrated compensatory effects. Immunoblots confirmed the decrease of BCRP, MRP4 and MFSD2A in BBTB endothelial cells after irradiation. Despite significant reduced efficiency, P-gp/BCRP efflux pump activity remains functional in endothelial cells and pericytes following irradiation.

Irradiation sensitizes the BBB, but to a lesser extent the BBTB, to the effects of pro-inflammatory cytokines. The observed decrease in P-gp/BCRP activity, as well as the involvement of MFSD2A, MRP4 and Claudin-5 regulation, warrant further investigations.

The online version contains supplementary material available at 10.1186/s12987-026-00778-6.

## Linked entities

- **Genes:** cldn5.L (claudin 5 (transmembrane protein deleted in velocardiofacial syndrome) L homeolog) [NCBI Gene 398929], ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429], ABCC4 (ATP binding cassette subfamily C member 4 (PEL blood group)) [NCBI Gene 10257], MFSD2A (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 84879], PGP (phosphoglycolate phosphatase) [NCBI Gene 283871]
- **Diseases:** Diffuse midline glioma (MONDO:0006033)

## Full-text entities

- **Genes:** ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, CD34 (CD34 molecule) [NCBI Gene 947], CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, ABCC1 (ATP binding cassette subfamily C member 1 (ABCC1 blood group)) [NCBI Gene 4363] {aka ABC29, ABCC, DFNA77, GS-X, MRP, MRP1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ABCC5 (ATP binding cassette subfamily C member 5) [NCBI Gene 10057] {aka ABC33, EST277145, MOAT-C, MOATC, MRP5, SMRP}, ABCC4 (ATP binding cassette subfamily C member 4 (PEL blood group)) [NCBI Gene 10257] {aka MOAT-B, MOATB, MRP4}, ABCG2 (ATP binding cassette subfamily G member 2 (JR blood group)) [NCBI Gene 9429] {aka ABC15, ABCP, BCRP, BMDP, CD338, CDw338}, Cldn5 (claudin 5) [NCBI Gene 12741] {aka MBEC1, Tmvcf}, CYP2S1 (cytochrome P450 family 2 subfamily S member 1) [NCBI Gene 29785] {aka CYPIIS1}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, PDGFRB (platelet derived growth factor receptor beta) [NCBI Gene 5159] {aka CD140B, IBGC4, IMF1, JTK12, KOGS, OPDKD}, ABCC2 (ATP binding cassette subfamily C member 2) [NCBI Gene 1244] {aka ABC30, CMOAT, DJS, MRP2, cMRP}, CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545] {aka ASGD6, CP1B, CYPIB1, GLC3A, P4501B1}, MFSD2A (MFSD2 lysolipid transporter A, lysophospholipid) [NCBI Gene 84879] {aka HsMFSD2A, MCPH15, MFSD2, NEDMISBA, NLS1, SLC59A1}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, CYP2D6 (cytochrome P450 family 2 subfamily D member 6 (gene/pseudogene)) [NCBI Gene 1565] {aka CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PCLAF (PCNA clamp associated factor) [NCBI Gene 9768] {aka KIAA0101, L5, NS5ATP9, OEATC, OEATC-1, OEATC1}, HEBP1 (heme binding protein 1) [NCBI Gene 50865] {aka HBP, HEBP}, Cdh5 (cadherin 5) [NCBI Gene 12562] {aka 7B4, Cd144, VE-Cad, VECD, VEcad, Vec}
- **Diseases:** ependymoma (MESH:D004806), Brain tumors (MESH:D001932), glioblastoma (MESH:D005909), cancer (MESH:D009369), oedema (MESH:C536897), neurotoxic (MESH:D020258), BBB (MESH:C536830), cytotoxic (MESH:D064420), Diffuse midline glioma (MESH:D005910), DIPG (MESH:D000080443), Inflammation (MESH:D007249), DSB (MESH:D019457), brain (MESH:D001927)
- **Chemicals:** RH (MESH:D012238), Verapamil (MESH:D014700), gentamicin sulfate (MESH:D005839), heparin (MESH:D006493), KCl (MESH:D011189), CaCl2 (MESH:D002122), Tween 20 (MESH:D011136), PBS (MESH:D007854), DTT (MESH:D004229), Calcium (MESH:D002118), GlutaMAX (MESH:C054122), glucose (MESH:D005947), DAPI (MESH:C007293), DMSO (MESH:D004121), Magnesium (MESH:D008274), CO2 (MESH:D002245), L-glutamine (MESH:D005973), tetrazolium (MESH:D013778), vitamin A (MESH:D014801), DHA (MESH:D004281), R123 (MESH:D020112), saccharose (MESH:D013395), Paraformaldehyde (MESH:C003043), lipid (MESH:D008055), F12 (MESH:C007782), MTT (MESH:C070243), Elacridar (MESH:C083501), streptomycin (MESH:D013307), DPM (MESH:C064754), SBB (MESH:C016118), fatty acid (MESH:D005227), Triton X-100 (MESH:D017830), methanol (MESH:D000432), NaCl (MESH:D012965), 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2 H-tetrazolium Bromide (MESH:C000598529), NaHCO3 (MESH:D017693), BHE (-), penicillin (MESH:D010406), rhodamine (MESH:D012235), oxygen (MESH:D010100), formazan (MESH:D005562), HEPES (MESH:D006531), LY (MESH:C017475)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** R206H, R248Q, K27M, C with 0
- **Cell lines:** AGS — Homo sapiens (Human), Gastric adenocarcinoma, Cancer cell line (CVCL_0139), DMG — Rattus norvegicus (Rat), Rat malignant glioma, Cancer cell line (CVCL_3581), HSJD — Homo sapiens (Human), Diffuse intrinsic pontine glioma, Cancer cell line (CVCL_VU71), DIPG-007 — Homo sapiens (Human), Diffuse intrinsic pontine glioma, Cancer cell line (CVCL_VU70), BBTB — Rattus norvegicus (Rat), Conditionally immortalized cell line (CVCL_LH99)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961863/full.md

---
Source: https://tomesphere.com/paper/PMC12961863